(1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality.
Patrícia EstevesSoraia Lopes LimaAnaly Salles de Azevedo MeloElisa Maria BeirãoMarcio NucciArnaldo Lopes ColomboPublished in: Mycoses (2020)
A high baseline serum BDG value was associated with therapeutic failure.